Conference Report: ‘Less is More’: defining modern bioanalysis

Author:

Dijksman Jessica1,Timmerman Philip2,Abbott Richard3,Barroso Begona4,Kloeppel Margarete Brudny5,Companjen Arjen6,Golob Michaela7,Gordon Ben8,Herling Christian9,Knutsson Magnus10,Luedtke Silke11,Rasmussen Birgitte Buur10,Stoellner Daniela12,Vieser Eva13,Young Graeme14,van Amsterdam Peter15

Affiliation:

1. Solusacta, The Netherlands

2. Janssen Research & Development, Belgium

3. Shire Pharmaceuticals, UK

4. Astellas, The Netherlands

5. Bayer Healthcare,Germany

6. Crucell, the Netherlands

7. Merck-Serono,Germany

8. Servier, UK

9. NovoNordisk, Denmark

10. Ferring Pharmaceuticals, Denmark

11. Boehringer Ingelheim, Germany

12. Novartis, Switzerland

13. Micromet AG, Germany

14. GlaxoSmithKline, UK

15. Abbott Healthcare Products, The Netherlands.

Abstract

The 4th Open Symposium of the European Bioanalytical Forum entitled ‘Less is More’ was held on 16–18 November 2011 at the Hesperia Tower Hotel, Barcelona, Spain. More than 50 interesting presentations were delivered covering areas with interest for the small- and large-molecule community – biomarker validation; regulations, including an update on new and emerging guidelines and on Global harmonization; technology updates; incurred sample stability; microdosing; dried blood spots and microsampling; challenges of ‘free’ and ‘total’ macromolecule quantification; stability issues in ligand binding assays or anomalous results. In excess of 450 delegates from more than 170 institutes and companies (industry, regulators and academia) from all global regions participated in the open and stimulating discussions. This manuscript provides an overview of the highlights discussed at the meeting.

Publisher

Future Science Ltd

Subject

Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry

Reference12 articles.

1. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

2. Guidance for Industry Bioanalytical Method Validation. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM), May (2001).

3. Guideline on Bioanalytical Method Validation. Committee for Medicinal Products for Human Use (CHMP), EMEA/CHMP/EWP/192217/2009.

4. AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration

5. Workshop/conference report—Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3